Your browser doesn't support javascript.
loading
Targeting ERK combined with apatinib may be a promising therapeutic strategy for treating oral squamous cell carcinoma.
Zhao, Tong-Chao; Liang, Si-Yuan; Zhou, Zhi-Hang; Ju, Wu-Tong; Zhang, Zhi-Yuan; Zhu, Dong-Wang; Zhong, Lai-Ping.
Afiliación
  • Zhao TC; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine Shanghai, China.
  • Liang SY; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology Shanghai, China.
  • Zhou ZH; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine Shanghai, China.
  • Ju WT; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology Shanghai, China.
  • Zhang ZY; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine Shanghai, China.
  • Zhu DW; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology Shanghai, China.
  • Zhong LP; Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine Shanghai, China.
Am J Cancer Res ; 11(6): 2960-2974, 2021.
Article en En | MEDLINE | ID: mdl-34249438
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China